Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation but the immune mechanisms leading to the diverse clinical manifestations of cGVHD remain unknown. In this study, we examined regulatory T cells (T reg ) in 57 transplant recipients (30 with cGVHD and 27 without active cGVHD) and 26 healthy donors. Phenotypic studies demonstrated decreased frequency of CD4+CD25+ T cells in patients with cGVHD compared to patients without cGVHD (p<0.0001) and healthy individuals (p<0.0001). Gene expression of T reg transcription factor FOXP3 was reduced in cGVHD patients compared to patients without cGVHD (p=0.009) or healthy donors (p=0.01). T-cell-receptorexcision-circle (TREC) assays for the evaluation of thymus activity revealed fewer TREC in both transplant groups compared to healthy donors (p<0.001 and p=0.02, respectively) although no difference was observed between patients with or without cGVHD (p=0.13). When tested in functional assays, T reg from both patient cohorts and normal individuals mediated equivalent levels of suppression. Collectively, these studies indicate that patients with active cGVHD have reduced frequencies of T reg but the function of these cells remains normal. These findings support the development of new strategies to increase the number of T reg following allogeneic HSCT to prevent or correct cGVHD.
Introduction
Chronic graft versus host disease (cGVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT) [1] [2] [3] . In most studies, between 30 and 75% of patients who survive after day-100 develop some clinical manifestations of cGVHD 1 .
Chronic GVHD occurs following engraftment of HLA-identical or HLA-mismatched stem cells and after non-myeloablative and ablative conditioning. Chronic GVHD is presumably mediated primarily by effector T cells and increasing degrees of HLA disparity between recipient and donor contribute to the incidence and severity of disease. However, the pathophysiology of cGVHD remains poorly understood. A paradoxical hallmark of cGVHD is the concurrent manifestation of autoimmunity, alloimmunity and immunodeficiency [1] [2] [3] . These clinical observations suggest that systemic dysregulation of the immune system may play a significant role in this disease.
CD4+CD25+ regulatory T cells (T reg ) are naturally occurring T cells whose function is to
suppress autoreactive lymphocytes and control normal immune responses 4, 5 . T reg develop in the thymus and in mouse models, depletion of this subset of cells leads to proliferation of normal lymphocytes and autoimmune destruction of various tissues and organs 6 . Allogeneic HSCT is known to affect thymic function and the reconstitution of T cell lineages. Poor reconstitution of the T reg subset after HSCT could lead to the inability to suppress autoreactive and alloreactive immune cells and contribute to cGVHD. The ability of T reg to delay the onset of acute GVHD or reverse established GVHD has previously been reported in several murine models [7] [8] [9] [10] [11] [12] . In humans, recent investigations of T reg after HSCT have generated conflicting results. One phenotypic study
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From suggested that cGVHD is associated with higher absolute numbers of circulating CD4+CD25+ T cells 13 . In contrast, molecular studies using quantitative PCR demonstrated lower expression levels of the T reg specific transcription factor FOXP3 in patients with both acute and chronic GVHD 14 . Another study found that CD4+CD25+ T reg cells were significantly reduced relative to the number of OX40+ activated cells in patients with cGVHD 15 .
Using phenotypic, molecular and functional methods, we examined CD4+CD25+ T reg cells in 30 patients with cGVHD after allogeneic HSCT, 27 patients without active cGVHD and 26 healthy controls. The diagnosis of cGVHD was established using clinically and histologically accepted criteria 16 . Both phenotypic and molecular assays indicated that patients with active cGVHD have a reduced frequency of circulating T reg cells compared to patients without active cGVHD and healthy controls. However, when isolated in vitro, T reg from patients and normal individuals appeared to exhibit similar levels of immune suppressive function. We also assessed thymic activity in patients and controls using a quantitative PCR assay for T cell receptor excision circles (TREC). The 2 patient groups had lower TREC values compared to healthy donors indicating that allogeneic HSCT substantially reduces thymic activity and this may contribute to T reg imbalance in these patients.
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Patients, Materials and Methods

Patients and samples
All patients included in this study were enrolled in clinical protocols approved by the DanaFarber/Harvard Cancer Center Investigational Review Board. Details of patient clinical history, treatment, HSCT outcome and symptoms of cGVHD are summarized in Table 1 . Written informed consent was obtained from each patient prior to sample collection. Patient PBMC were isolated from blood samples by density gradient centrifugation and cryopreserved in aliquots before being analyzed.
Flow cytometry
Thawed PBMC were analyzed by flow cytometry using a series of monoclonal antibodies (Beckman Coulter, Fullerton CA) including anti-CD3-PC5, anti-CD4-PE, anti-CD8-FITC and anti-CD25-FITC (clone 1HT44H3). The frequency of each cell subset was calculated as a percentage of positive cells in the total lymphocyte gate.
Quantitative PCR for FOXP3 expression
Total RNA was extracted from PBMC using Trizol reagent according to the manufacturer's guidelines (INVITROGEN, Carlsbad, CA). Complementary DNA was then prepared using 2µg of RNA using the Superscript III cDNA first-strand synthesis kit (INVITROGEN). Real-time PCR was performed in triplicates using SYBR Green PCR Master Mix (Applied Biosystems, 
T reg suppression assays
Suppression of anti-viral T cell reactivity was evaluated using ELISPOT assays for the secretion of IFNγ . Briefly, 10 . Anti-viral T cell reactivity was assessed before and after complete depletion of CD25+ cells using anti-CD25 microbeads (Miltenyi). After overnight incubation, plates were successively labeled with a biotinylated anti-IFNγ secondary mAB (Mabtech) followed by streptavidin alkaline phosphatase (Mabtech). Spots were revealed using nitroblue tetrazolium and brom-chlor-indolyl phosphate (Promega). Percent inhibition due to the CD25+ cells was calculated as follows: % Inhibition = (# spots using CD25 depleted cells -# spots using undepleted cells) X 100 # spots using CD25 depleted cells
Suppression of T cell proliferation by T reg
Standard assays for the suppression of proliferation were performed as previously described with minor modifications 19 . Briefly, CD4+CD25-and CD4+CD25+ cells were purified from patient and donor PBMC using the Miltenyi magnetic separation system according to the manufacturer's instructions. 1x10 Pairwise group comparisons are not adjusted for multiple comparisons. Measure of correlation was calculated and tested using the Spearman rank method. Smoothing spline curve estimation technique was used to characterize the pattern of correlation. Several statistical approaches were explored to establish cut-off points for %CD4+CD25+. These approaches included taking the 95th or 99th percentile value, taking the mean +2*STD value from the log-transformed distribution and a classification and regression trees. The cut-off point of 3.0% was established from these approaches. Linear and logistic regression analyses for T reg were performed to adjust differences in patient baseline characteristics between patients with cGVHD and without cGVHD. 
Decreased frequency of CD4+CD25+ T cells associated with cGVHD
Percentages of CD4+CD25+ in total PBL were determined by flow cytometry to evaluate the frequency of T reg relative to other blood lymphocytes. As shown in Figure 1 , patients with
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From cGVHD had significantly lower percentages of CD4+CD25+ in total PBL compared with patients without active cGVHD (p=0.007). The median value for the cGVHD group was also lower than that observed for healthy donors however this difference did not reach statistical significance (p=0.29). Patients without active cGVHD also had significantly higher CD4+CD25+ values than the control population (p=0.0005). Interestingly, both patient groups had decreased percentages of CD3+CD4+ in total PBL compared to healthy individuals (p<0.0001, data not shown). These results support the view that CD4+CD25+ cells are independently regulated among total CD3+CD4+ cells. Because of the limited number of patients with moderate or severe cGVHD, we were not able to evaluate the association of CD4+CD25+ cells with severity of cGVHD.
Since CD25 is not a unique marker of T reg and can also be expressed on activated T cells, the wide range of percent CD4+CD25+ values shown in Figure 1 could reveal the presence of effector rather than regulatory T cells in some samples. We therefore considered alternative methods of comparing different groups. Based on the distribution of the normal donors, we established a cut-off point of 3.0 to use in comparing different groups. As seen in Table 2 , using this cut-off point, 50% (15/30) of patients with cGVHD had low %CD4+CD25+ (≤3.0%) whereas only 3.7% (1/27) of patients without active cGVHD (p<0.0001) and 8% (2/26) of normal individuals had low %CD4+CD25+ (p<0.0001). As the stem cell source, prior acute GVHD and frequency of related donors appeared to be different between patients with cGVHD and patients without cGVHD, we performed a linear regression model for %CD4+CD25+ on continuous scale and a logistic model for dichotomous %CD4+CD25+ (>3.0% vs. <=3.0%) after adjusting all these factors and age but excluding patient treatment. Immunosuppressive therapy was not adjusted because nearly all patients with cGVHD received immunosuppressive drugs.
Active cGVHD was the only significant factor for lower frequency of CD4+CD25+ in PBL (p=0.01 from a logistic regression model and p=0.049 from a linear regression model). There was no correlation between phenotypic determination of T reg and the time of sample collection post-transplant (p=0.29) or sex matching (p=0.29). Likewise there was no correlation between %CD4+CD25+ and the source of stem cells among patients without cGVHD (p=0.82).
Decreased expression of FOXP3 in PBL from patients with cGVHD
To assess T reg in patient and donor samples we also measured the expression of the T reg specific transcription factor FOXP3 using a quantitative PCR assay. Figure 2A Spearman's Correlation test (r s =0.60, p=0.0007). Acute GVHD (aGVHD) is a predominant risk factor for cGVHD. We next analyzed whether FOXP3 expression correlated with cGVHD independently of previous occurrence of aGVHD. As shown in Figure 2C , the lowest levels of expression of FOXP3 were observed in patients who had cGVHD after aGVHD. Remarkably, patients with de novo cGVHD (no previous aGVHD) had reduced FOXP3 expression levels compared to patients without acute or chronic GVHD. These results indicate that reduced T reg cells in these patients correlates with the development of cGVHD independently of aGVHD.
As mentioned previously, within the no-cGVHD group 12 patients previously had cGVHD that had resolved at the time of sample collection. We compared flow cytometric and molecular T reg measurements for these patients to those who had never developed cGVHD. As reported in Table 3 , there was no significant difference between the 2 subgroups, strongly suggesting that resolution of cGVHD is accompanied by a readjustment of T reg values towards normal values.
Inverse correlation between CD4+CD25+ T reg and CD3+CD8+ T cells
In addition to CD4+CD25+ T reg , we also examined other lymphocyte populations in all samples from patients and healthy controls. Effector T cells are predominately CD3+CD8+ T cells and phenotypic studies revealed a highly heterogeneous distribution of CD3+CD8+ values for the cGVHD group (Figure 3 A) . In contrast, patients without cGVHD showed little variation of CD3+CD8+ T cells compared to healthy individuals. As shown in Figure 3 B, we found a striking inverse correlation between the percentages of CD4+CD25+ and CD3+CD8+ T cells in samples from patients with cGVHD (r s = -0.81, p<0.0001), providing further evidence for a physiological interaction between these 2 subpopulations. This correlation was also highly Figure 4A shows the results obtained using samples from 15 patients with cGVHD tested in this assay. In these experiments, percent inhibition due to the presence of CD25+ cells was calculated to be between 0% (2 samples) and 59.2%. Figure 4B 
Patient T reg cells exert normal levels of suppression
The previous series of experiments established a correlation between the number of T reg and their level of suppressive activity. We next investigated whether T reg isolated from patients with or without cGVHD as well as from healthy donors displayed similar levels of suppressive activity.
Using antibody coated magnetic particles, CD4+CD25+ T reg were purified from patients and donors and tested for their capacity to inhibit the proliferation of autologous CD4+CD25-T cells stimulated with anti-CD3. Results obtained from 5 patients with cGVHD, 7 patients without cGVHD and 5 controls are shown in Figure 5 . Although this analysis was limited by the number of samples available, we could not detect any significant differences between the suppressive activities of T reg cells isolated from patient and donor groups. These findings suggest that T reg isolated from cGVHD patients exert similar levels of suppression as T reg purified from patients without cGVHD or healthy donors.
Decreased thymic activity following allogeneic HSCT
To examine thymic activity, TREC copy numbers in DNA extracted from patient and control samples were measured using quantitative RT-PCR. As shown in Figure 6 , patients with or without chronic GVHD showed significant decrease in TREC compared to healthy donors (p<0.001). These data support previous reports that thymic function is substantially impaired following allogeneic HSCT. However, in contrast to other published studies we could not find any significant difference between the 2 patient groups 20, 21 . In addition, there was no correlation between TREC values and either %CD4+CD25+ cells or FOXP3 levels (data not shown).
For
Discussion
Several recent studies in murine models have demonstrated the critical role of T reg in controlling GVHD after allogeneic HSCT [7] [8] [9] [10] [11] [12] . In humans, it is still unclear whether impairment of T reg populations post-transplant contributes to the development of acute or chronic GVHD. Thus far, only 3 studies have examined T reg following allogeneic HSCT, using either phenotypic or molecular techniques and these studies have generated conflicting results [13] [14] [15] . To address this issue we performed a retrospective analysis of T reg following allogeneic HSCT using independent phenotypic markers as well as functional assays. Moreover, we focused entirely on chronic GVHD and results in patients with active clinical manifestations of disease were compared to patients without active disease as well as healthy controls. In addition to phenotypic analysis, we undertook a functional assessment of T reg in our patients and donor samples. In most studies, the functional suppression of immune responses has correlated well with the phenotypic assessment of T reg . However, there are also well-documented For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From
